Ensight-AI Awarded FDA's Breakthrough Device Designation for their ECGvision-TTR© Technology for Early Detection of ATTR-Cardiomyopathy
David Stemerman Co-founder, Chief Executive Officer and Chief Investment Officer, Centerbook Partners